Lynch syndrome — also known as hereditary non-polyposis colorectal cancer — is the most common hereditary form of colorectal cancer. In the United States, about 150,000 new cases of colorectal cancer are diagnosed each year and approximately 3 to 5% of these cancers are caused by Lynch syndrome. It’s estimated that 1 in 300 people may be … Read more
On September 24, 2015, in a sixth floor room at Boston Children’s Hospital, 5-year-old Logan Lesselroth pressed the button that started the transfer of his newly harvested blood stem cells to his 3-year-old sister, Gianna. “This,” Gianna told him, “is a gift from your body.” The path to that moment and the stem cell transplant’s … Read more
Good nutrition plays a key role in cancer prevention and survivorship. With the right pantry items, patients can help manage side effects of treatment and potentially lower risk of recurrence. In this Cancer Conversations podcast episode, Dana-Farber nutritionist Stacy Kennedy, MPH, RD, CSO, discusses the best diet for cancer patients, as well as tips for … Read more
By Bob Ferris I thought I could handle things myself when my wife, Ruth, got cancer – and for a while I did. Six years ago, at age 52, Ruth was diagnosed with stage III ovarian cancer. She has a family history of ovarian and endometrial cancers, and was always good about getting regular screenings, … Read more
While the end of active cancer treatment may bring some relief, it can also bring many questions and anxieties for young patients and their families. In this Cancer Conversations podcast episode, Lisa Diller, MD, chief medical officer of the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, discusses topics around fertility, growth, late effects of treatment, … Read more
Although cervical cancer incidence and death rates have decreased thanks to regular screenings, thousands of women in the U.S. are still affected by the disease every year. In this Cancer Conversations podcast episode, Ursula Matulonis, MD, medical director of the Gynecologic Oncology Program in the Susan F. Smith Center for Women’s Cancers at Dana-Farber, joins … Read more
Bridgette West sparkled last fall in the “Fight Song” music video created by patients at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. But before the 2-year-old became a social media standout with her dancing, she and her family faced challenges that went far beyond a cancer diagnosis. In the summer of 2015, after struggling for … Read more
Although there is no cure for metastatic breast cancer, new developments in treatment and research are helping patients live longer and experience a better quality of life. In this Cancer Conversations podcast episode, Eric Winer, MD, director of Breast Oncology Program in the Susan F. Smith Center for Women’s Cancers at Dana-Farber, discusses the latest … Read more
With new research in immunotherapy and targeted therapy, treatment options for blood cancer patients are rapidly expanding. Combination therapies have also caused much excitement among researchers and physicians, and ongoing clinical trials are continuing to look at new strategies that use multiple drugs for fighting these diseases. In this Cancer Conversations podcast episode, Irene Ghobrial, … Read more
Although ovarian cancer can sometimes be difficult to treat, researchers and physicians are finding new ways to approach the disease, making way for promising alternatives to the traditional chemotherapy treatments. In this Cancer Conversations podcast episode, Ursula Matulonis, MD, Panos Konstantinopoulos, MD, PhD, and Susana Campos, MD, MPH, from the Gynecologic Oncology Program at the Susan … Read more
Although only a small percentage of breast cancers are considered hereditary, genetic testing and cancer risk — specifically the BRCA1/2 genes — have made many headlines in recent years. But what exactly does it mean to have a BRCA mutation, and what do women need to know? In this Cancer Conversations podcast episode, Huma Rana, … Read more
While the medical treatments for cancer can help fight off deadly disease, these life-saving therapies can also cause physical and emotional side effects. For some patients, the use of integrative therapies can help ease or eliminate treatment-related symptoms. In this Cancer Conversations podcast episode – the first of the series – David Rosenthal, MD, former … Read more
Prostate cancer is the most common cancer affecting men in the United States, after skin cancer. Yet, “most men die with prostate cancer, not of prostate cancer,” says Mark Pomerantz, MD, a medical oncologist in Dana-Farber’s Lank Center for Genitourinary Oncology, who recently shared the latest in prostate cancer research and treatment during a live … Read more
Here’s a closer look at five things to know about risk of breast cancer and gynecologic cancers, including cervical, endometrial, and ovarian cancers. African American women are most likely to be diagnosed with breast cancer at a younger age. Breast cancer usually occurs in women over age 55, but young women can also develop the … Read more
American women have a 12 percent lifetime risk of being diagnosed with breast cancer, the second most common cancer in women, according to the American Cancer Society. While young women do get breast cancer, the disease is much more common in women aged 60 and older. Rachel Freedman, MD, MPH, a medical oncologist at the … Read more
Updated April 13, 2015 While one of the most common cancers in both men and women, colorectal cancer remains a very preventable disease, says Jeffrey Meyerhardt, MD, MPH, clinical director of Dana-Farber’s Center for Gastrointestinal Oncology. “Most of these cancers develop over a period of years,” he says. “While not preventable in everyone, the earlier … Read more
Women born with mutations in the genes BRCA1 or BRCA2 have an increased risk of developing breast and ovarian cancer, but the degree of increase depends on a variety of factors. Not all mutations within these genes raise the risk equally. A study published earlier this year tracked breast and ovarian cancer occurrences over a 75-year … Read more
Growing up in the San Francisco area, Cigall Kadoch, PhD, had a passion for puzzles. The daughter of a Moroccan-born, Israeli-raised father and a mother from Michigan who together developed an interior design business, Kadoch excelled in school and pretty much everything else. Above all, she loved to solve brain-teasers. In high school, however, Kadoch … Read more
Many associate cancer treatment with chemotherapy and radiation therapy, but for many women with gynecologic cancers, surgery is often the first line of defense. Colleen Feltmate, MD, director of minimally invasive surgery in gynecologic oncology at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), shares insight into surgical options to treat these cancers. Minimally Invasive vs. Open … Read more
By Eric Bender Multiple myeloma is a poster child for recent advances in treatment: In the past decade, the U.S. Food and Drug Administration (FDA) approved no fewer than nine treatments for the blood cancer, and several more drug approvals appear to be near. Not coincidentally, multiple myeloma is also a popular target that researchers … Read more